Extended release formulations of a proton pump inhibitor
作者： Mitsuru Mizuno , Manabu Murakami , Kiyoshi Iwamoto , Shigeru Aoki , Kenji Moroshima
DOI:
关键词:
摘要: The invention provides extended release formulations of proton pump inhibitor, such as an formulation rabeprazole, comprising amount rabeprazole between 30 and 90 mg having AUC 900 1750 ng*hr/mL other properties.
lens.org 参考文章(45)
Ian R. Wilding, Stanley S. Davis, Massoud Bakhshaee, Howard N. E. Stevens, Robert A. Sparrow, John Brennan, Gastrointestinal Transit and Systemic Absorption of Captopril from a Pulsed-Release Formulation Pharmaceutical Research. ,vol. 9, pp. 654- 657 ,(1992) , 10.1023/A:1015806211556
John Paul Carter, Extended release compositions of proton pump inhibitors ,(2005)
Felix Theeuwes, John Urquhart, Intestine drug delivery ,(1987)
Chih-Ming Chen, Diltiazem controlled release formulation ,(1996)
Pontus Bergstrand, Peter Wang, Pharmaceutical formulation comprising omeprazole ,(1999)
Gerd-Ulfert Heese, Fritz Stanislaus, Gerhard Schneider, Josef Maximilian Hofer, Hans-Joachim Huber, Pharmaceutical formulation as well as a process for its preparation ,(1989)
Rango Dietrich, Hartmut Ney, Oral-administration forms of a medicament containing pantoprazol ,(1992)
H Nakai, A Ohnishi, T Ogawa, S Yasuda, J Hasegawa, N Morishita, Y Tomono, Y Shimamura, Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers. International Journal of Clinical Pharmacology and Therapeutics. ,vol. 32, pp. 466- 473 ,(1994)
Chih-Ming Chen, Pulsatile particles drug delivery system ,(1993)